KR930016100A - 약제학적 조성물 - Google Patents

약제학적 조성물 Download PDF

Info

Publication number
KR930016100A
KR930016100A KR1019930000673A KR930000673A KR930016100A KR 930016100 A KR930016100 A KR 930016100A KR 1019930000673 A KR1019930000673 A KR 1019930000673A KR 930000673 A KR930000673 A KR 930000673A KR 930016100 A KR930016100 A KR 930016100A
Authority
KR
South Korea
Prior art keywords
composition
pharmaceutically acceptable
treating
pharmaceutical composition
tumors
Prior art date
Application number
KR1019930000673A
Other languages
English (en)
Other versions
KR100274101B1 (ko
Inventor
볼라그 베르너
프란시스 그립포 조우지프
레빈 아써
Original Assignee
프리돌린 클라우스너, 롤란트 보러
에프. 호프만-라 로슈 에이지
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25239599&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR930016100(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 프리돌린 클라우스너, 롤란트 보러, 에프. 호프만-라 로슈 에이지 filed Critical 프리돌린 클라우스너, 롤란트 보러
Publication of KR930016100A publication Critical patent/KR930016100A/ko
Application granted granted Critical
Publication of KR100274101B1 publication Critical patent/KR100274101B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

9-시스 레틴산, 이의 염 및 에스테르는 악성 종양 및 전악성종양성 상피 병변, 피부 광손상, 피지 분비 증가에 의해 유발된 질환, 및 건선의 치료에 사용될 수 있다.

Description

약제학적 조성물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (5)

  1. 9-시스 레틴산, 약제학적으로 허용되는 이의 염 또는 약제학적으로 허용되는 이의 가수분해성 에스테르 및 치료적 불활성의 약제학적으로 허용되는 담체를 함유하는 약제학적 조성물.
  2. 제1항에 있어서, 전악성종양 또는 암전구성 상피 병변 또는 상피 종양을 치료하기 위한 조성물.
  3. 제1항에 있어서, 광손상된 피부와 관련된 상태를 치료하기 위한 조성물.
  4. 제1항에 있어서, 피지 분비를 감소시키기 위한 조성물.
  5. 제1항에 있어서, 건선을 치료하기 위한 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019930000673A 1992-01-22 1993-01-20 9-시스 레틴산을 함유하는 약제학적 조성물 KR100274101B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US82374192A 1992-01-22 1992-01-22
US7/823,741 1992-01-22
CH07/823,7410 1992-01-22

Publications (2)

Publication Number Publication Date
KR930016100A true KR930016100A (ko) 1993-08-26
KR100274101B1 KR100274101B1 (ko) 2000-12-15

Family

ID=25239599

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930000673A KR100274101B1 (ko) 1992-01-22 1993-01-20 9-시스 레틴산을 함유하는 약제학적 조성물

Country Status (2)

Country Link
US (1) US5428071A (ko)
KR (1) KR100274101B1 (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968989A (en) 1991-12-18 1999-10-19 The Salk Institute For Biological Studies Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
US7056954B2 (en) * 1991-12-18 2006-06-06 The Salk Institute For Biological Studies Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
US6506917B1 (en) * 1991-12-18 2003-01-14 The Salk Institute For Biological Studies Compounds and compositions useful for modulation of processes mediated by RXR
US7655699B1 (en) 1992-04-22 2010-02-02 Eisai Inc. Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
US8541469B2 (en) * 1997-08-23 2013-09-24 Glaxo Group Limited Treatment of cell-mediated immune diseases
EP0908179A1 (en) 1997-08-23 1999-04-14 Werner Bollag Treatment of cell-mediated immune diseases
US6495406B1 (en) * 2000-08-31 2002-12-17 Micron Technology, Inc. Method of forming lightly doped drain MOS transistor including forming spacers on gate electrode pattern before exposing gate insulator
JP2004020220A (ja) * 2002-06-12 2004-01-22 Pioneer Electronic Corp 通信システム及び方法、通信端末装置、通信センタ装置、並びにコンピュータプログラム
DE10305138A1 (de) * 2003-02-07 2004-08-26 Axxima Pharmaceuticals Ag Gegen Hepatitis C-Virusinfektionen nützliche Verbindungen und Substanzen
AU2003294757A1 (en) * 2002-11-29 2004-06-23 Axxima Pharmaceuticals Ag Formulations useful against hepatitis c virus infections
EP1527774A1 (en) 2003-11-03 2005-05-04 Basilea Pharmaceutica AG New formulation for retinoid-containing soft gelatin capsules
US20120070518A1 (en) * 2004-01-12 2012-03-22 Natrogen Therapeutics International, Inc. Methods and compositions for treating psoriasis
US20060189893A1 (en) * 2005-01-06 2006-08-24 Diamics, Inc. Systems and methods for detecting abnormal cells
US20060161076A1 (en) * 2005-01-06 2006-07-20 Diamics, Inc. Systems and methods for collection of cell clusters

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA713539B (en) * 1970-06-23 1972-02-23 Hoffmann La Roche Pharmaceutical compositions
LU86969A1 (fr) * 1987-08-12 1989-03-08 Oreal Association de derives de pyrimidine et de retinoides en composants separes pour induire et stimuler la croissance des cheveux et diminuer leur chute

Also Published As

Publication number Publication date
KR100274101B1 (ko) 2000-12-15
US5428071A (en) 1995-06-27

Similar Documents

Publication Publication Date Title
NO930206D0 (no) Farmasoeytiske blandinger
RU93005355A (ru) Фармакологические композиции
KR930016100A (ko) 약제학적 조성물
Plewig et al. Anti-inflammatory effects of 13-cis-retinoic acid: an in vivo study
RU93047799A (ru) Композиции, содержащие ретиноевые кислоты и токоферол
DE3850109D1 (de) 13-trans-retinsäureester.
SE8804036L (sv) Ny anvaendning av 11,28-dioxa-4-azatricklo (22.3.1.04.9)-oktakos-18-en-derivat och farmaceutiska kompositioner innehaallande desamma
CA2061703A1 (en) Formulations containing hyaluronic acid
IT7827167A0 (it) Procedimento e apparecchiatura perl'ottenimento di acqua di elevata purezza priva di germi e di particelle, per preparati medicinali per iniezioni e per scopi tecnici.
EP0297733A3 (en) Pharmaceutical compositions comprising catecholic butanes
FI863976A0 (fi) Terapeutisk komposition.
KR920004387A (ko) 진통제 및 피부질환 치료용 국소용 소염제로서의 4-치환된 디하이드로피리도[4,3-d]피리미딘
DE68919009D1 (de) Verwendung von 5-Amino-salicylsäure für die Behandlung von Hautkrankheiten.
SE8102161L (sv) "3,7,11,15-tetrametyl-2,4,6,10,14-hexadekapentaensyra
IE780534L (en) Pharmaceutical composition
KR970069969A (ko) 신규한 레티노이드
ATE120090T1 (de) Behandlung gealterter haut mit oraler 13-cis- retinsäure.
ATE86611T1 (de) Topische vorstufen von arzneimitteln zur behandlung von akne und hautkrankheiten.
FI910308A0 (fi) Vattenloesliga vitamin a preparationer foer applicering pao huden.
FR2081478A1 (en) Treatment of acne and psoriasis with vitamin - a acids
FR2455610A1 (fr) Nouveaux steroides inhibiteurs de la 5a-reductase, utiles notamment pour le traitement de l'acne et leur procede de preparation
IT1257884B (it) Formulazioni farmaceutiche per il trattamento di malattie periferiche vascolari a base di vincamina o di un suo sale farmaceuticamente accettabile.
BG48345A1 (en) Hepatoprotective means
FR2347042A1 (fr) Composition pharmaceutique contenant une substance heterocyclique destinee au traitement de maladies de la peau

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
G170 Publication of correction
FPAY Annual fee payment

Payment date: 20100825

Year of fee payment: 11

LAPS Lapse due to unpaid annual fee